Stockscreener 앱 받기
0.429
2.54%
-0.0112
시간 외 거래:
.43
0.001
+0.23%
전일 마감가:
$0.4402
열려 있는:
$0.4409
하루 거래량:
48,614
Relative Volume:
0.77
시가총액:
$11.95M
수익:
$6.56M
순이익/손실:
$-14.92M
주가수익비율:
-0.4165
EPS:
-1.03
순현금흐름:
$-33.87M
1주 성능:
-10.53%
1개월 성능:
-2.72%
6개월 성능:
-53.27%
1년 성능:
-65.68%
1일 변동 폭
$0.411
$0.4799
1주일 범위
$0.411
$0.51
52주 변동 폭
$0.334
$1.5754
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
SLGL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLGL
Sol Gel Technologies Ltd
|
0.429 | 11.95M | 6.56M | -14.92M | -33.87M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-19 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-10-21 | 재개 | Jefferies | Hold |
| 2019-12-31 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-31 | 재확인 | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd 주식(SLGL)의 최신 뉴스
Rosacea Treatment Market Growth in Future Scope 2024-2031 | - openPR
Solar Lighting System Market Trends and Future Opportunities 2024-2032 - openPR
Acne Vulgaris Pipeline Therapeutics Assessment Report 2024 (Updated) - openPR
Global Solar Street Lighting Market to Reach USD 12.38 Billion by 2029, Growing at a CAGR of 14.5% - openPR
Revolutionary Solar Lighting Innovations for 2024 - openPR
Sol-Gel Technologies Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Sol-Gel receives Nasdaq compliance extension By Investing.com - Investing.com Nigeria
Sol-Gel Technologies Reports Strong Q3 2024 Results - TipRanks
SolGel Technologies (SLGL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Sol-Gel receives Nasdaq compliance extension - Investing.com India
SEALSQ updates on minimum bid price non-compliance - MSN
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement - The Manila Times
Microlise Group Reassures Investors After Cyber Incident - MSN
Solar Lighting System Market Current Status and Future Prospects till 2031 - openPR
Smudge-Free Innovations: 2024 Global Market Insights on Anti-Fingerprint Coatings In The Latest Report - WhaTech
GlobalData Executes Share Buyback Program - MSN
Sol Gel Tech earnings beat by $0.04, revenue topped estimates - Investing.com South Africa
Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Form 424B3 Sol-Gel Technologies - StreetInsider.com
SEC Form 424B3 filed by Sol-Gel Technologies Ltd. - Quantisnow
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - The Manila Times
Sol-Gel Technologies Q3 Revenue Surges to $5.4M, Narrows Losses Amid Strategic Growth | SLGL Stock News - StockTitan
Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline - Yahoo Finance
Tretinoin Market 2024 Trends Evaluation, Geographical - openPR
Solar Lighting Market: Technological Innovations and Future - openPR
Paragon 28, Inc. (FNA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
SOL (HK) Company Limited Announces Launch of Health-Focused Gevity and Plenty Products - openPR
Rosacea Clinical Trials 2024: EMA, PDMA, FDA Approvals, - openPR
Next-Generation Solar Cell Market Size, Latest Trends, Growth Status, Top Major Players And Forecast To 2033 - openPR
SLGL (Sol-Gel Technologies) 50-Day SMA : $0.66 (As of Nov. 02, 2024) - GuruFocus.com
Rosacea Market Growth, Insights, Demand, Forecast to 2033 - WhaTech
Raymond James Downgrades Sol-Gel Technologies (SLGL) - MSN
(PDF) Effect of various amount of ammonium hydroxide on morphology of silica nanoparticles grown by sol-gel - ResearchGate
Rosacea Treatment Market Size, Share, and Trends Analysis - openPR
Actinic Keratosis Treatment Market Size, Share, Revenue, Trends, and Drivers For 2024-2033 - EIN News
Corrosion and Scale Inhibitors Market to Grow by USD 3.53 Billion (2024-2028) as Demand Surges, with AI Driving Market Transformation- Technavio - Lelezard
Solar Street Lighting Market Trends: USD 38.15 Bn Value with - openPR
Sol-gel Technology Market Leading Players Overview - Economica
Acne Vulgaris Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2024-2034), States DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health - Barchart
Papulopustular Rosacea Market Revenue to Expand Significantly - openPR
Tretinoin Market Anticipates Positive Growth Through 2031 | BASF, LGM Pharma, Gyma Laboratories. - openPR
Retinoic Acid Receptor Alpha Industry Size, Regional Demand, Trends and Forecast to (2024-2034) - உங்கள் குரல்
IIT Roorkee licensed technology with EnrgEnv Smart Chemicals and Materials Pvt. Ltd. - India Education Diary
SolGel Technologies (SLGL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
Armistice Capital LLC Sells 46,000 Shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL) - Defense World
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Update - Defense World
Sol-Gel Technologies Announces Upcoming Special Meeting - TipRanks
Sol–Gel Reaction of Tetraethoxysilane, Hexaethoxydisiloxane, and Octaethoxytrisiloxane: Differences in Siloxane Precursor Oligomers Depending on Raw Materials - ACS Publications
Solana Surges: Seeker Device Launch Ignites SOL Price Rally - PC-Tablet
Solana SmartPhone Set To Release In 2025, Will SOL Rally Past Rival GoodEgg (GEGG) - NewsBTC
Will Solana’s SAGA Phone Become A Success? Whales Side with New AI Social Scoring Crypto, Rallied 110% - NewsBTC
Sol Gel Technologies Ltd (SLGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):